Emmes, a US-based global, full-service Clinical Research Organisation (CRO), announced on Thursday that it has named Kristin Judge as its new chief growth officer.
In the new role, Judge will head business development and all sales support activities, including inside sales and proposal development, and will support both public sector and biopharma groups.
Judge has served as the head of CRO and clinical data management systems sales at Veeva Systems. She has headed a global sales team at Labcorp Drug Development and started her career at PPD, where she gained clinical operations and sales experience.
GSK Launches COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US
AstraZeneca's Lynparza receives US approval for BRCA-mutated prostate cancer
Nykode Therapeutics expands clinical collaboration with Roche for advanced cervical cancer trial
Caliway Biopharmaceuticals commences CBL-0204 Phase 2b study patient recruitment
Adiso Therapeutics completes Phase 1b multiple ascending dose clinical trial assessing ADS051
InDex Pharmaceuticals signs license agreement with Viatris Japan
Pfizer receives FDA approval for RSV vaccine in older adults
Brii Biosciences doses first subject in BRII-297 phase one clinical trial